Phase I trial segment has been expected to grow at the fastest growth rate during the forecast period, owing to the increase in its applications in
investigative new drug (IND) sector, technological advancements, and the rising government initiatives to improve the healthcare sector in emerging economies.
M2 PHARMA-November 15, 2018-Generon Receives
Investigative New Drug Approval from China SFDA for A-319 to Treat Patients with B Cell Malignancies
Stemedica's MSCs are also being used in five other FDA-approved clinical trials under
Investigative New Drug (IND) status.
The decision to seek an Orphan Drug Designation submission is part of PixarBio's plan to prepare an
Investigative New Drug Application (NDA) for spinal cord injury.
This US FDA orphan drug designation allows the company to move forward with its preparation of an
Investigative New Drug Application and proposal of clinical trials.
During this fiscal year, the company also plans to file an
Investigative New Drug (IND) for a pivotal Phase 3 clinical trial of Revimmune, to treat numerous autoimmune diseases with an initial indication targeting refractory relapsing-remitting Multiple Sclerosis.
The company plans to submit an IND (
Investigative New Drug Application) this year.
[para] filing of an
Investigative New Drug Application (INDA) with the Food and Drug Administration, along with all required documentation;
Preclinical data submitted as part of the company's
Investigative New Drug application demonstrated that HuCNS-SC cells protect host photoreceptors and preserve vision in a well-established animal model of retinal disease that is relevant to dry AMD.
Stem cell company Stemedica Cell Technologies Inc reported on Friday that the company has filed an
Investigative New Drug (IND) application with the US Food and Drug Administration (FDA) for treatment of stroke with adult allogeneic mesenchymal stem cells.
MedImmune currently anticipates filing an
Investigative New Drug (IND) application with the United States Food and Drug Administration for the lead anti-IL-9 antibody in the second half of 2003.